Intelligent Historical Cash Flow
| INBS Stock | USD 1.48 0.01 0.68% |
Analysis of Intelligent Bio cash flow over time is an excellent tool to project Intelligent Bio Solutions future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Non Cash Items of 152.4 K or Capital Expenditures of 303 K as it is a great indicator of Intelligent Bio ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Intelligent Bio Solutions latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Intelligent Bio Solutions is a good buy for the upcoming year.
Intelligent | Build AI portfolio with Intelligent Stock |
About Intelligent Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Intelligent balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Intelligent's non-liquid assets can be easily converted into cash.
Intelligent Bio Cash Flow Chart
Add Fundamental
Most accounts from Intelligent Bio's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Intelligent Bio Solutions current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intelligent Bio Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. At this time, Intelligent Bio's Capital Expenditures is comparatively stable compared to the past year. Total Cash From Financing Activities is likely to gain to about 7 M in 2025, despite the fact that Free Cash Flow is likely to grow to (9.4 M).
Intelligent Bio cash flow statement Correlations
Click cells to compare fundamentals
Intelligent Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Intelligent Bio cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 12.1M | (4.3M) | (6.7M) | 4.8M | (5.3M) | (5.0M) | |
| Free Cash Flow | (11.3M) | (3.7M) | (7.9M) | (9.8M) | (9.9M) | (9.4M) | |
| Change In Working Capital | (4.9M) | 2.4M | 78.9K | (701.9K) | (720.8K) | (684.7K) | |
| Begin Period Cash Flow | 427.3K | 12.6M | 8.2M | 1.5M | 6.3M | 3.6M | |
| Other Cashflows From Financing Activities | 1.8M | (880.2K) | (1.1M) | 1.7M | 1.5M | 803.4K | |
| Other Non Cash Items | 704.4K | 2.5M | (1.8M) | (122.3K) | 160.4K | 152.4K | |
| Total Cash From Operating Activities | (11.3M) | (3.4M) | (7.4M) | (9.6M) | (9.7M) | (9.2M) | |
| Net Income | (7.1M) | (8.3M) | (10.7M) | (10.2M) | (10.6M) | (11.1M) | |
| Total Cash From Financing Activities | 733.9K | 23.4M | 1.4M | 14.6M | 4.6M | 7.0M | |
| End Period Cash Flow | 12.6M | 8.2M | 1.5M | 6.3M | 1.0M | 968.9K | |
| Change To Account Receivables | (1.0M) | 1.8M | (293.9K) | (135.8K) | (2.9M) | (2.7M) | |
| Change To Netincome | 38.1K | 681.4K | 2.5M | 2.2M | 2.5M | 1.6M | |
| Change To Liabilities | 2.4M | (973.0K) | 242.7K | 1.1M | 1.3M | 1.3M | |
| Issuance Of Capital Stock | 24.9M | 0.0 | 2.8M | 12.9M | 4.6M | 6.2M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Intelligent Stock Analysis
When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.